Target intelligence / Profile preview

Novel transcript, antisense to STAB2 (ENSG00000257737)

Target
ENSG00000257737
Molecular classification
Other (long non-coding RNA, lncRNA)
01

Overview

ENSG00000257737, designated as "novel transcript, antisense to STAB2," is a long non-coding RNA (lncRNA) locus transcribed antisense to the STAB2 (stabilin 2) gene. Natural antisense transcripts (NATs), such as this, are widespread in the human genome and can modulate gene expression through various mechanisms, including chromatin remodeling, transcriptional interference, and mRNA stability regulation. Studies suggest that antisense transcription in general may alter the chromatin environment and dynamics of sense transcript production, potentially buffering gene expression and histone acetylation states in a locus-specific manner. However, to date, there is no direct evidence or experimental characterization defining the function or clinical relevance of ENSG00000257737, and it is not considered a classical drug target. In summary, ENSG00000257737 is a long non-coding RNA annotated as antisense to the protein-coding gene STAB2, lacking evidence as a therapeutic target, with unclear biological and clinical significance.

Other names
lncRNA ENSG00000257737novel transcript antisense to STAB2
02

Mechanism of action

Not applicable. No drugs or therapeutics target this entity.

03

Biological functions

Antisense long non-coding RNAs can influence the expression, stability, and processing of sense transcripts, often through chromatin modification or transcriptional interference.However, specific functions for this transcript are uncharacterized.
04

Disease associations

Unknown/Other.There is no established disease association or mechanistic evidence linking this lncRNA to disease phenotypes.
05

Safety considerations

None established.Lack of functional and pathological data.
06

Interacting drugs

None known.

1 more in the full profile.

07

Biomarkers

None established for this transcript.

Beyond the preview

Go deeper on Novel transcript, antisense to STAB2 (ENSG00000257737).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to STAB2 (ENSG00000257737).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call